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FOREWORD
In the period of John Paul's lifetime in medicine, great changes have
occurred in the face and philosophy of infectious disease. His work has
contributed greatly to those changes. Being of sound and inquisitive mind,
itchy foot, and unlimited resources, he has moved through many intellectual
and geographic areas in unending pursuit of pathogenic facts and infer-
ences. When he went to Yale in 1928 he joined the stimulating company of
Blake and Trask in an association which I, too, had enjoyed. This team of
Paul and Trask produced a remarkable combination of bold and meticulous
research, bringing clinical, pathological, and microbiological competence to
epidemiological studies of poliomyelitis. As Director of the Commission on
Neurotropic Virus Diseases for fifteen years, he brought together a splendid
group of investigators whose contributions have been legendary. And, of
course, studies of hepatitis grew under his art and persuasion.
It has been a rare privilege to have had close and continued association
with John Paul over these many years; to watch the determined approach
to difficult problems with courageous and imaginative skill. But there have
also been many periods to enjoy in a relaxed manner, social, and cultural
interests he so expertly developed. It has been a great life whose lively
facets will continue to glisten and to gain luster long after the official
academic curtain has fallen.
Many forget that John Paul was earlier a student of respiratory disease
and its familial distribution. When I first knew him he was, like so many
of the modern virologists, a pneumococcus expert. It seems quite fitting,
then, to present as a token of respect for his versatile achievements and of
personal affection, some remarks on the Problems of Acute Respiratory
Disease.
* * *
The oft-repeated statement that the infectious diseases are conquered
seems ridiculous when one considers the number of cases and com-
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plexity of acute respiratory disease. The U.S. National Health Survey
reports that in the year July 1957-June 1958' among the noninstitution-
alized population, 36.5 percent of work-loss days, 45 percent of bed-
disability days, and 67 percent of school-loss days were caused by acute
respiratory disease. It constituted 60 to 66 percent of all acute conditions
in every age group. In comparison with 764 million days of bed-disability
for all chronic conditions, were 593 million days caused by acute respiratory
disease. Although 1957-58 was an epidemic influenza year, data for
1958-59' and 1959-60' still emphasize the great segment of illness and
disability created by acute respiratory disease as measured in total incidence,
incidence rates, or bed days.
The burden is especially heavy during the developmental period of life.
Since we have a "younging" population, with an estimated 40 percent
under 20 years of age by 1970, it is clear that the bulk of respiratory
disease looms progressively larger. The vigorous, productive years are also
repeatedly disrupted. The work-loss from acute respiratory disease in
1957-58 was 219 million days; in 1958-59, 190 million, in comparison with
226 million work days lost from circulatory, digestive, and arthritic diseases
and impairments from injury or other origin. These urchins of frequent,
repetitive respiratory illnesses clearly take a formidable toll. On the basis
of general experience and comparison of mortality rates from respiratory
disease, it seems evident that the situation is no less prominent in other
nations and regions where other infections and nutritional inadequacies
present additional serious loads.
The size of the problem is compounded by the multiplicity and hetero-
geneity of the etiological agents: bacterial, viral, fungal, and others. This
complexity was early postulated on epidemiologic and immunological
grounds, but the actual identification of numerous serologic types among
pneumococci and other bacteria prepared investigators for a similar pattern
among the respiratory viruses. It developed rapidly with recognition of the
influenza viruses, the adenoviruses, the hemadsorption viruses, some
enteroviruses, some not yet clearly classified, reoviruses, or a group which
the British Salisbury team suggests may be sufficiently different and
characteristic to classify separately.
The response to infection varies widely from the inapparent, the afebrile
with respiratory symptoms, and the mild febrile illness to severe and
pneumonic disease. Variation occurs also with age, season, experience,
strain, or special conditions such as institutional or military life. Therefore,
a great bulk of the illness is more an epidemiologic syndrome than distinct
clinical syndromes readily associated with specific etiological agents. The
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popular diagnosis of "a virus" is thus fairly precise. Nevertheless, some of
the agents tend to incite a certain set of clinical signs with greater regular-
ity than others so that within these limits of clarity an etiological relation-
ship may be suspected.
INFLUENZA VIRUS STRAINS
Generally, clinical influenza is recognized in epidemics occurring at
relatively short intervals. They are most frequently associated with type A
virus. For a decade or so strains of a closely related antigenic character
spread about the world in large and small prevalences so as to give a high
level of immunity. A popular thesis held that these recurrences were the
result of a directional alteration by which the successive strains were pro-
gressively discarding the characteristic antigen of the previous year and
picking up entirely new constitutive antigens. The evidence does not appear
in keeping with that idea.
Rather, the strains of a period appear to comprise a group or family
with close similarities, but varying quantitatively in a random fashion
about a central pattern. This hypothesis, which seems in accord with the
cumulative information, is that the virus comprises a large number of
demonstrable antigenic components which may, by rearrangement, develop
phenotypic alterations about the prototype. They do not represent pro-
gressive recessions from the initial strain becoming increasingly remote
with the passage of time.'
Nevertheless, at intervals of 10 years or so, we have witnessed the
appearance of major variants whose dominant antigen is relatively new to
most of the human population. They are the Asian variant of type A
(1957), the A' (1947), the initial A (PR8-WS 1933-34), and the swine
influenza virus. That they are not entirely novel is indicated by the reduced
incidence of the disease in the older segments of the population, by the
demonstration of antibody in serum of the adult population before the
recognized appearance of the strain, as in 1947 and 1957; and by the appear-
ance of antibody to swine virus, in convalescent children for example, at a
time when the virus as such is not demonstratably prevalent. Each of these
features tends to emphasize the expression of common antigens existent in
various strains.!
The pattern of antibody response appears in infancy and childhood to
be largely directed against the dominant antigen of the prevalent virus
family. With successive exposure that antibody is steadily reinforced by the
stimulus of similar, though secondary, antigens of infecting strains so that
it persists at high levels and constitutes the antibody characteristic of that
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cohort throughout life. In the meantime, antibody to other constituent anti-
gens is also acquired and a broad resistance, less influenced by strain
characteristics, is thus developed.'
What are the mechanisms by which these major sports come into general
circulation? It has been suggested that they arise in many parts of the
world simultaneously rather than spreading from area to area by transfer.
It seems quite unlikely that, with the numerous arrangements possible,
one combination would erupt spontaneously in such a diffuse manner. The
evidence of spread from place to place has been so clearly charted repeated-
ly, especially in 1957, that little doubt remains of this fact. Moreover, the
antibody pattern of the population in widely separate regions is much the
same in a given period of time, indicating that most strains do become
disseminated throughout the world whether associated with recognized
large pandemics or not.
What are the other possibilities? Dr. Richard E. Shope has long been
interested in the possibility that a masked form of virus persists and can
be activated by varied, provoking stresses." Our knowledge would require
that there be a malleable viral nucleus which can be activiated to yield
various antigenic patterns rather than a relighting of the same old virus.
I do not think this too difficult to visualize as a biological phenomenon, and
it could occur in man or in other species.
But there is an alternative proposal: The virus maintains an essentially
fixed character in another host and will reenter the human population
when conditions are favorable. The swine virus of the United States is an
example. The same idea has been expressed by Mulder9 about the 1957
Asian strain-that it has been resident among swine in Asia, maintaining
its antigenic composition over many years, before reappearing in the human
population. We agree that a virus with a similar dominant antigen was
prevalent in the 1889-90 period and that the antibodies to this antigen
found in older people before 1957 refer to their childhood experience with
a similar strain. But if animal sources of fixed strains are the common
basis for human epidemic or pandemic recurrences, then certainly this
reservoir has yet to be demonstrated. The recent identification of strains
from horses and ducks has not led to serological recognition of their dissem-
ination in man; nor have the animal surveys since 1957 led to any significant
evidence of distribution of the 1957 virus in various animal species.
Zhdanov10 has suggested that the animal strains are old human strains
which have become so established in those hosts as to represent errant dead
end kids. In the gospel of St. Matthew it tells of the casting of devils into
swine; that was probably influenza. But we are dealing in these respects
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with only secular revelations, and the entire subject must be kept under
critical scrutiny.
On the other hand animal diseases, even respiratory infections, are not
frequently transmitted from man to man. (Perhaps pneumonic plague is
an exception.) The rapid variation in influenza stains suggests rapid trans-
fer. The widespread rapid distribution of the numerous influenza mutants
emphasizes the active role of human agencies. But even sharp antigenic
variation is not necessarily associated with increased virulence or epidemic
dispersibility. In fact, these two characteristics are to a large extent in-
dependent variables. We have recorded the shift with years in the age
distribution of antibody in the human population to the various type A
families and believe that this altering base of immunity is an important
factor in selection and dissemination of the major influenza variants. Since
the breadth of antibody is dependent upon experience with strains of varied
composition, inexperienced children exhibit the highest incidence of in-
fection by any or all strains, and also most limited reflection of viral
antigens. With the passage of time antibody to succeeding dominants is
acquired, but large gaps develop in the immunity of the community to
viral antigens which prevailed when the older segments of the population
were young. These gaps invite a rearrangement of viral antigens to enter the
population and provide the opportunity for rapid passage and development
of epidemic potency. Thus, a resurgence of older or suppressed antigens
occurs to complete a cycle of antigenic repression and renewal.
Such a variant may arise in any region, and if transfer to other suscep-
tibles is furthered by crowded conditions, it may increase its epidemic
potential, possibly its virulence, and proceed on its adventurous path. I
believe that the 1957 strains are notable support for this hypothesis and
that a swinelike strain can be expected one of these days. That the antigens
for this remodeling are still available in current strains has been already
indicated in data from the virus laboratory at the University of Michigan.'
Maassab obtained indications that fresh glacial acetic extracts of Asian
strain induced antibody in mice which cross reacted with PR8 and swine
strains, while whole virus did not. Berlin and Minuse both showed that
hyperimmunization with the Asian strain gave cross protection against the
PR301 strain of 1954. Davenport and Hennessy have recently shown that
immunization of rabbits with ether-purified HA fractions of the PR8 strain
induced cross titers to FM-1 and swine strains while the intact virus did
not. Mulder9, and Lief and Henle' have brought additional evidence of
the common antigens in Asian virus and earlier A strains. It is on this basis
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that our concepts of control and prevention by vaccination have been
developed.
OTHER RESPIRATORY AGENTS
While influenza represents the most consistent and prominent cause of
general epidemics it is also apparent that the large body of day-by-day
respiratory infections is of other etiology. The institutional studies of
Huebner, Bell, Chanock, and co-workers? have sharply emphasized the
steady smog of respiratory infection which constitutes the child's garden
of viruses. Again, they are commonly clinical nondescripts, epidemiolo-
gically obscure, and even identification of a viral or bacterial agent is at
times of doubtful etiological significance. Nevertheless, certain patterns
have emerged in distinct form.
One of the most interesting variations is the behavior of the adeno-
viruses. Originally recognized as unsuspected residents of tonsillar tissue,
they have become increasingly notable as agents of sustained epidemics in
military recruits, especially types 4 and 7.' They may account for as much
as 80 percent of the febrile respiratory illness in those populations but,
surprisingly, are ordinarily of small moment among college populations of
similar age. It is possible that in recruit populations a minor infection is
accentuated by the concentration and constant renewal of susceptibles
under unusual physiological stress to a position of exaggerated clinical
severity. Theoretically, one would like to postulate the provocation of a
latent virus under these conditions. Serologic evidence indicates, however,
that recruits do not arrive with a latent infection but acquire it during the
period of intensive basic training.
Seasoned troops remain essentially immune. It appears, then, that the
viruses remain in the camp, reaching steadily for the new arrivals, and are
therefore a place infection. Among children Bell and co-workers? have
noted the apparent reactivation or reappearance of virus in the same
individuals at sporadic intervaals for months after the initial infection.
Moreover, there are indications that the reappearance is more common in
the winter than in the summer months. This type of intermittent excretion
may well be the source for continued infection among recruits.
Certain aspects of the human situation are appearing also among adeno-
virus infections being recognized in calves, pigs, and chickens. There are
many intriguing possibilities in this finding. But the hopeful fact is that
inactive adenovirus vaccines containing the commonly involved types have
been repeatedly shown to be highly effective. Certain studies have demon-
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strated that combined influenza and adenovirus vaccine is highly effective
against both sets of viral respiratory disease.
The types prevalent among children and civilian adolescents areordinarily
different from the military, and often illness or antibodies develop without
clear evidence of onset. It seems likely, as with pneumococci or strepto-
cocci, that different types form groups of different significance.
I shall not pursue further the etiogolical analysis of acute viral respira-
tory disease except to emphasize again the complexity and multiplicity of
the agents. It is important to recall however, that bacterial agents continue
to play an important role in acute respiratory disease, especially with
respect to mortality. Influenza and pneumonia, mostly bacterial, are still
the great killers of infants and a progressive threat to those over 45 years
old. More than 350,000 cases of "streptococcal sore throat" were reported
in the United States in 1960. In Michigan 9,300 cases of scarlet fever and
1,700 cases of rheumatic fever were reported in 1960. The roles of hemo-
philus influenza and pneumococcus are still of major consequence.
PREVENTIVE MEASURES
With this array of participating agents, what control or preventive
measures can be visualized?
1. I believe that there still remains a hope for hygienic barriers compatible
with normal social activity. Our inadequacy cannot seem much greater
than that of the fecal hygienist of a century or so ago. If essential extra-
human reserviors exist, as with tuberculosis or brucellosis, efforts can be
directed toward their suppression.
2. The progressive knowledge of antigens, antibodies, and immunity
continues to direct attention to specific preventive immunization. Vaccina-
tion against epidemic influenza can be effective if properly used, with
preparations combining the proper types and strains. The evidence exists
as well for certain adenoviruses. Is it, then, necessary to assume that each
and every one of the agents must be used in vaccines to give the total effect
required? I do not know. It may be, as I think has been the case in entero-
virus outbreaks, that the suppression of certain agents paves the way for a
buildup of others.
On the other hand, rapidly increasing knowledge points to the sameness
in structure and basic pathogenesis among many of these agents. It has been
easy to visualize and demonstrate the feasibility of compounding vaccines
with numerous components and various agents. This practice is enhanced
by the use of adjuvants so that small amounts of purified antigens can be
immunologically effective and multiple antigens can be employed. They can
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be more potent as primary immunizers and boosters, and their effects can
be sustained at higher levels for longer periods. At the moment this is the
best outlook for specific immunization. But advances in the knowledge of
virus transformation, recombination, and genetic determinants may provide
simpler methods for compiling a basic immunizing unit of many potentials
from essential chemical components.
3. Some form of enhanced general resistance of high efficiency has been
considered for a long time. There is little doubt in my mind that much of
the decline in mortality from certain diseases, such as scarlet fever, before
antibiotics was the result of increased protection in childhood with con-
sequent effects on the vigor of physiological resistance. One day the many
splinters may be molded into a functional system which can be modified
intelligently. Complement, opsonins, phagocytosis, clonal selection of cells
or their stimulation, and properdin, all indicate the possibilities. New agents
and new adaptation might well break through these basic mechanisms. A
broad refractoriness such as occurs in cellular repair, or the recently dis-
covered interferon, point in other directions. Interference with infection or
epidemics (Sydenham) may be developed with attenuated viruses. But I
believe that, of itself, this approach provides only a first line of defense.
4. Finally, in my opinion, the most likely resources at present are related
to chemoprophylaxis and therapy. The data from our laboratory alone have
shown the feasibility of protecting against experimental disease, such as
paralytic poliomyelitis in monkeys. The rapidly advancing knowledge at
the molecular, cellular, and organic levels of the mechanisms of viral
development and infection can be expected to reveal common factors or re-
actions susceptible to chemical alteration. Consequently, the hope is to
override the restrictions of multiple immunological types just as is true in
chemoprophylactic control of pneumococci, streptococci, and others, in
which the prophylactic effects have been clearly demonstrated by reduction
of mortality and disease incidence. Our studies"~'7 are clearly pointing out
the way in which drugs may differentiate the significance of RNA and DNA
in viral development and exert specific influences on the RNA and DNA
viruses.
The problem is still great; the need for new ideas, persistent optimism,
and bold undertakings is even greater.
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